Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
biotech
boston blog main
boston top stories
cancer
clinical trials
investing
3
×
life sciences
national blog main
3
×
national top stories
roche
3
×
san francisco blog main
san francisco top stories
biotech ipos
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
merck
national
new york blog main
new york top stories
nkarta
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
venture capital
vertex pharmaceuticals
vir biotechnology
What
bio
drug
roundup
advantages
alliance
bar
brings
bristol
buy
calls
cancer
changing
color
crispr
days
despite
expect
family
gamble
growing
hardest
hit
hottest
hours
hunters
ipo
kudos
leaves
market
medco’s
medicines
mover
myers’s
new
notifying
october
patients
payers
phone
physicians
Language
unset
Current search:
roche
×
investing
×
" national blog main "
×
amgen
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone